Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors-Reference-Cited by-同舟云学术

Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors

Published:2019-01-30 Issue:3 Volume:45 Page:187-194
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Annovazzi Alessio,Vari Sabrina,Giannarelli Diana,Pasqualoni Rosella,Sciuto Rosa,Carpano Silvia,Cognetti Francesco,Ferraresi Virginia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference15 articles.

1. Targeted agents and immunotherapies: optimizing outcomes in melanoma;Nat Rev Clin Oncol,2017

2. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;N Engl J Med,2017

3. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials;Eur J Cancer,2017

4. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006);Lancet,2017

5. The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases;Cancer Immun,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of immune microenvironment in hepatocellular carcinoma: current advances in CT and MRI imaging techniques;Chinese Journal of Academic Radiology;2024-02-11

2. Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-04

3. Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18F-FDG PET/CT;Clinical Nuclear Medicine;2023-04-05

4. Molecular imaging for cancer immunotherapy;iRADIOLOGY;2023-03

5. PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score;Life;2023-02-22